The EWSRI/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene

C. Filion, T. Motoi, A. B. Olshen, M. Laé, R. J. Emnett, D. H. Gutmann, A. Perry, M. Ladanyi, Y. Labelle

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

The NR4A3 nuclear receptor is implicated in the development of extraskeletal myxoid chondrosarcoma (EMC), primitive sarcoma unrelated to conventional chondrosarcomas, through a specific fusion with EWSR1 resulting in an aberrant fusion protein that is thought to disrupt the transcriptional regulation of specific target genes. We performed an expression microarray analysis of EMC tumours expressing the EWSR1/NR4A3 fusion protein, comparing their expression profiles to those of other sarcoma types. We thereby identified a set of genes significantly overexpressed in EMC relative to other sarcomas, including PPARG and NDRG2. Western blot or immunohistochemical analyses confirm that PPARG and NDRG2 are expressed in tumours positive for EWSR1/NR4A3. Bioinformatic analysis identified a DNA response element for EWSR1/NR4A3 in the PPARG promoter, andband-shift experiments and transient transfections indicate that EWSR1/NR4A3 can activate transcription through this element. Western blots further show that an isoform of the native NR4A3 receptor lacking the C-terminal domain is very highly expressed in tumours positive for EWSR1/NR4A3, and co-transfections of this isoform along with EWSR1/NR4A3 indicate that it may negatively regulate the activity of the fusion protein on the PPARG promoter. These results suggest that the overall expression of PPARG in EMC may be regulated inpart by the balance between EWSR1/NR4A3 and NR4A3, and that PPARG may play a crucial role in the development of these tumours. The specific up-regulation of PPARG by EWSR1/NR4A3 may also have potential therapeutic implications.

Original languageEnglish
Pages (from-to)83-93
Number of pages11
JournalJournal of Pathology
Volume217
Issue number1
DOIs
StatePublished - Jan 1 2009

Keywords

  • Chromosomal translocations
  • EWSR1/NR4A3
  • Extraskeletal myxoid chondrosarcoma
  • Fusion proteins
  • Nuclear receptors
  • PPARG
  • Target genes

Fingerprint Dive into the research topics of 'The EWSRI/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene'. Together they form a unique fingerprint.

  • Cite this

    Filion, C., Motoi, T., Olshen, A. B., Laé, M., Emnett, R. J., Gutmann, D. H., Perry, A., Ladanyi, M., & Labelle, Y. (2009). The EWSRI/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene. Journal of Pathology, 217(1), 83-93. https://doi.org/10.1002/path.2445